Thermo Fisher Scientific Company Profile (NYSE:TMO)

About Thermo Fisher Scientific

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: TMO
  • CUSIP: 88355610
Key Metrics:
  • Previous Close: $158.63
  • 50 Day Moving Average: $149.67
  • 200 Day Moving Average: $149.61
  • 52-Week Range: $127.65 - $160.68
  • Trailing P/E Ratio: 31.04
  • Foreward P/E Ratio: 15.65
  • P/E Growth: 1.63
  • Market Cap: $62.35B
  • Outstanding Shares: 394,600,000
  • Beta: 1.1
  • Net Margins: 11.06%
  • Return on Equity: 15.41%
  • Return on Assets: 7.35%
  • Debt-to-Equity Ratio: 0.71%
  • Current Ratio: 1.45%
  • Quick Ratio: 0.99%
Additional Links:
Companies Related to Thermo Fisher Scientific:

Analyst Ratings

Consensus Ratings for Thermo Fisher Scientific (NYSE:TMO) (?)
Ratings Breakdown: 2 Hold Ratings, 10 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $170.91 (8.16% upside)

Analysts' Ratings History for Thermo Fisher Scientific (NYSE:TMO)
DateFirmActionRatingPrice TargetDetails
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 -> $162.00View Rating Details
1/23/2017Jefferies Group LLCLower Price TargetHold$163.00 -> $160.00View Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$163.00View Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)Reiterated RatingConviction-Buy -> Conviction-Buy$170.00 -> $168.00View Rating Details
11/20/2016Leerink SwannReiterated RatingBuy$175.00View Rating Details
10/7/2016Bank of America CorpSet Price TargetBuy$180.00View Rating Details
9/22/2016J P Morgan Chase & CoInitiated CoverageOverweight$180.00View Rating Details
9/9/2016Cleveland ResearchDowngradeBuy -> NeutralView Rating Details
7/29/2016Citigroup Inc.Boost Price TargetBuy$160.00 -> $182.00View Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00View Rating Details
7/22/2016BTIG ResearchUpgradeNeutral -> Buy$180.00View Rating Details
5/19/2016Morgan StanleyReiterated RatingBuyView Rating Details
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 -> $155.00View Rating Details
1/29/2016Stifel NicolausLower Price Target$158.00 -> $150.00View Rating Details
1/29/2016KeyCorpLower Price TargetOverweight$152.00 -> $150.00View Rating Details
1/29/2016Barclays PLCLower Price TargetOverweight$165.00 -> $160.00View Rating Details
1/7/2016Cowen and CompanyBoost Price Target$160.00View Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00View Rating Details
10/6/2015ArgusInitiated CoverageBuy$145.00View Rating Details
7/23/2015Robert W. BairdBoost Price TargetOutperform$148.00 -> $160.00View Rating Details
4/23/2015Cantor FitzgeraldSet Price TargetBuy$148.00View Rating Details
(Data available from 2/23/2015 forward)


Earnings History for Thermo Fisher Scientific (NYSE:TMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thermo Fisher Scientific (NYSE:TMO)
Current Year EPS Consensus Estimate: $9.16 EPS
Next Year EPS Consensus Estimate: $10.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$1.72$1.73$1.73
Q2 20162$1.99$2.01$2.00
Q3 20162$1.96$1.99$1.98
Q4 20163$2.38$2.43$2.40
Q1 20173$2.02$2.16$2.07
Q2 20173$2.27$2.30$2.28
Q3 20173$2.23$2.29$2.26
Q4 20173$2.42$2.61$2.55
Q1 20181$2.37$2.37$2.37
Q2 20181$2.53$2.53$2.53
Q3 20181$2.53$2.53$2.53
Q4 20181$2.72$2.72$2.72
(Data provided by Zacks Investment Research)


Current Dividend Information for Thermo Fisher Scientific (NYSE:TMO)
Annual Dividend:$0.60
Dividend Yield:0.38%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:11.79% (Based on Trailing 12 Months of Earnings)
6.55% (Based on Current Year Consensus EPS Estimate)
5.94% (Based on Next Year Consensus EPS Estimate)

Dividend History for Thermo Fisher Scientific (NYSE:TMO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Thermo Fisher Scientific (NYSE:TMO)
Insider Ownership Percentage: 0.52%
Institutional Ownership Percentage: 87.80%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.72View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.60View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.68View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.96View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.00View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.70View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.00View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.00View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.00View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.00View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.00View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.00View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.00View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.00View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.00View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.00View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.25View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.00View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.00View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.00View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.00View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.00View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.00View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.34View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.00View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.00View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.00View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.85View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.50View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.35View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.00View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.12View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.50View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.48View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.88View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.00View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Thermo Fisher Scientific (NYSE:TMO)
News IconLeading stocks in today’s market: Thermo Fisher Scientific Inc. (NYSE:TMO) (NYSE:TMO) - February 23 at 2:00 AM
News IconSmart Money Buying the Price Weakness of Thermo Fisher Scientific Inc (TMO) (NYSE:TMO) - February 22 at 9:00 PM logoPatent Royalties Curbed as Supreme Court Backs Thermo Fisher (NYSE:TMO) - February 22 at 9:00 PM logoThermo Fisher Backed by Supreme Court in Promega Patent Case (NYSE:TMO) - February 22 at 9:00 PM logoThermo Fisher Comes Out on Top in Promega Patent Case (NYSE:TMO) - February 22 at 9:00 PM logoThermo Fisher unit prevails in Supreme Court patent case (NYSE:TMO) - February 22 at 9:00 PM logoThermo Fisher did not infringe genetic-testing patent, U.S. top court says (NYSE:TMO) - February 22 at 10:22 AM
News IconWhat Analysts are Predicting For Zimmer Biomet Holdings, Inc. (ZBH), Thermo Fisher Scientific Inc. (TMO)? - The USA Commerce (NYSE:TMO) - February 21 at 4:41 PM
News IconAsuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer (NYSE:TMO) - February 20 at 7:19 PM
News IconTop Dividend Stock Pick: Thermo Fisher Scientific Inc. (TMO) (NYSE:TMO) - February 17 at 7:02 PM
News IconImpact of Brokerage Rating on Thermo Fisher Scientific Inc(TMO) (NYSE:TMO) - February 17 at 7:02 PM
News IconLarge Outflow of Money Witnessed in Thermo Fisher Scientific Inc (NYSE:TMO) - February 16 at 8:06 PM
News IconThermo Fisher Scientific Inc (TMO) Shares Bought by Marvin & Palmer Associates Inc (NYSE:TMO) - February 16 at 8:06 PM
News IconThermo Fisher Scientific Inc (NYSE:TMO) Price Target Expected At $168.538 - Transcript Daily (NYSE:TMO) - February 15 at 6:31 AM logoBRIEF-Thermo Fisher Scientific receives early termination of Hart-Scott-Rodino waiting period for acquisition of Finesse Solutions (NYSE:TMO) - February 13 at 8:50 PM logoThermo Fisher Scientific (TMO) Granted Early HSR Termination for Finesse Solutions Acquisition (NYSE:TMO) - February 13 at 8:50 PM logoThermo Fisher Scientific (TMO) Granted Early HSR Termination for Finesse Solutions Acquisition - (NYSE:TMO) - February 13 at 3:48 PM logoThermo Fisher Scientific Receives Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Finesse Solutions, Inc. (NYSE:TMO) - February 13 at 3:48 PM
News IconForward Earnings Estimate of Thermo Fisher Scientific Inc(TMO) - Highland Mirror (NYSE:TMO) - February 12 at 3:05 AM
News IconThermo Fisher Scientific Inc (TMO) Stake Reduced by Douglass Winthrop Advisors LLC (NYSE:TMO) - February 11 at 10:05 PM
News IconHot Stocks Among Investors: Royal Caribbean Cruises Ltd. (RCL), Thermo Fisher Scientific Inc. (TMO) - Post Analyst (NYSE:TMO) - February 10 at 6:06 AM
News IconIs It Time to go for Thermo Fisher Scientific Inc. (TMO), AmerisourceBergen Corporation (ABC)? - StockNewsJournal (NYSE:TMO) - February 10 at 6:06 AM
News IconLong Term Growth review of Thermo Fisher Scientific Inc (NYSE:TMO) - The Newburgh Press (NYSE:TMO) - February 7 at 2:59 AM logoThermo Fisher Scientific Innovations Designed to Accelerate Research, Productivity and Discovery on Display at SLAS 2017 (NYSE:TMO) - February 6 at 9:57 PM
News IconTop Gainers of the Day: Thermo Fisher Scientific Inc. (NYSE:TMO) from Medical Laboratories & Research (NYSE:TMO) - February 6 at 9:57 PM
News IconImpact Score Of Thermo Fisher Scientific Inc (NYSE:TMO) At 88 - Stock Observer (NYSE:TMO) - February 4 at 8:26 PM
News IconHealthcare Most Traded Stock: Thermo Fisher Scientific Inc.'s (TMO) (NYSE:TMO) - February 4 at 5:10 AM
News IconThermo Fisher Scientific Inc. (NYSE:TMO) from Medical Laboratories & Research – Todays Top Gains (NYSE:TMO) - February 4 at 5:10 AM
News IconThe Thermo Fisher Scientific Inc (TMO) Stake Decreased by S&CO Inc (NYSE:TMO) - February 3 at 6:17 AM
News IconThermo Fisher Scientific Inc. (NYSE:TMO) Could Offer Over 20% Upside Potentials (NYSE:TMO) - February 2 at 6:05 AM
News IconAs Thermo Fisher Scientific (TMO) Shares Rose, Sound Shore Management INC Has Trimmed by $192.28 Million Its Holding (NYSE:TMO) - February 2 at 6:05 AM logoQ4 2016 Thermo Fisher Scientific Inc Earnings Release - Before Market Open (NYSE:TMO) - February 2 at 6:05 AM logoThermo Fisher (TMO): Tops Q4 Earnings, Misses Revenues (NYSE:TMO) - February 2 at 6:05 AM logoThermo Fisher CEO Says M&A Funnel Is 'Pretty Full' (NYSE:TMO) - February 2 at 6:05 AM logoThermo Fisher Scientific, Inc. : TMO-US: Dividend Analysis : December 15th, 2016 (record date) : By the numbers : January 31, 2017 (NYSE:TMO) - February 2 at 6:05 AM logoEdited Transcript of TMO earnings conference call or presentation 31-Jan-17 1:30pm GMT (NYSE:TMO) - February 2 at 6:05 AM logoThe Hot Stock: Thermo Fisher Scientific Jumps 6.4% (NYSE:TMO) - February 2 at 6:04 AM
News IconEarnings Parade Rolls On, What Are Analysts Saying About Thermo Fisher Scientific Inc (NYSE:TMO)? - Wall Street Beacon (NYSE:TMO) - February 1 at 6:58 AM logoWhy Momenta Pharmaceuticals, Ally Financial, and Thermo Fisher Scientific Jumped Today (NYSE:TMO) - January 31 at 7:01 PM
News IconNortheast Investment Management Lifted Thermo Fisher Scientific INC (TMO) Position by $3.13 Million (NYSE:TMO) - January 31 at 4:10 AM
News IconAre Analysts Predicting a Near-Term Upswing For Thermo Fisher Scientific Inc (NYSE:TMO)? - Wall Street Beacon (NYSE:TMO) - January 30 at 10:59 AM logoMedical Products Stocks' Earnings on Jan 31: ZBH, TMO, ABC (NYSE:TMO) - January 30 at 10:59 AM logoThermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : January 30, 2017 (NYSE:TMO) - January 30 at 10:59 AM
News IconThermo Fisher Scientific Inc (NYSE:TMO) Stock Price Target Given At $168.307 - Transcript Daily (NYSE:TMO) - January 29 at 2:50 AM
News IconOne Stock Analysts Are Watching - Thermo Fisher Scientific Inc (NYSE:TMO) (NYSE:TMO) - January 28 at 9:50 PM
News IconThermo Fisher Scientific Inc TMO Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 19122016] Prices from USD $250 (NYSE:TMO) - January 27 at 4:30 PM
News IconThermo Fisher Scientific INC (TMO) Holder Athena Capital Advisors LLC Trimmed Its Position by $9.98 Million (NYSE:TMO) - January 27 at 4:30 PM logoWeitz Funds Comments on Thermo Fisher Scientific (NYSE:TMO) - January 27 at 6:17 AM
News IconThermo Fisher Scientific INC (TMO) Holder Lombard Odier Asset Management Switzerland Sa Decreased Its Holding by $4.75 Million as Market Value Rose (NYSE:TMO) - January 26 at 6:23 AM
News IconUpdate on Thermo Fisher Scientific Inc. (NYSE:TMO) for the day (NYSE:TMO) - January 26 at 6:23 AM


What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Thursday, November 10th. Shareholders of record on Thursday, December 15th will be given a dividend of $0.15 per share on Monday, January 16th. This represents a $0.60 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Tuesday, December 13th.

Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?

13 brokers have issued 12 month target prices for Thermo Fisher Scientific's stock. Their forecasts range from $155.00 to $182.00. On average, they anticipate Thermo Fisher Scientific's stock price to reach $170.91 in the next year.

When will Thermo Fisher Scientific announce their earnings?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, April, 26th 2017.

What are analysts saying about Thermo Fisher Scientific stock?

Here are some recent quotes from research analysts about Thermo Fisher Scientific stock:

  • According to Zacks Investment Research, "Thermo Fisher ended the year 2016 on a mixed note with adjusted earnings ahead of the Zacks Consensus Estimate and sales lagging the same. We remain encouraged by the company’s recent product launches along with strong emerging markets growth. In this regard, over the past three months, Thermo Fisher traded neck on neck with the Zacks categorized Medical Instruments industry. However, the company has started to outdo the broader industry on strong fourth-quarter bottom line performance and a solid outlook. We also look forward to Thermo Fisher’s acquisition of FEI Company which is going to boost its performance in life-science research. We also await the integration and expected synergy of Affimetrix. On the flip side, as expected, Thermo Fisher’s top-line performance in the quarter was affected by four less selling days resulting in flat organic growth. Competitive pressure and currency headwinds add further woes." (2/13/2017)

  • Evercore ISI analysts commented, "When all is said in done we will remember 4Q as being generally uneventful, with guidance coming in better than feared as investors had become concerned re the impact from slowing biopharma demand (didn't really occur), mixed A&G trends and an incremental headwind from Fx. The level of consistency we see from TMO is unusual in this challenging healthcare environment and likely helps to justify valuation that is certainly not inexpensive on an EV / EBITDA basis (particularly in a rising rate world). That being said with so few places to hide in a difficult healthcare tape, we would expect TMO's superior EPS growth to help shares to remain a preferred equity, particularly given its status as a visible compounder. Thus despite today's sharp move in shares (up a bit more than we would have anticipated) we reiterate our Buy rating as risk / reward continues to be asymmetrically biased upward." (1/31/2017)

Who owns Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include State Street Corp (4.03%), FMR LLC (1.24%), Glenview Capital Management LLC (0.93%), Janus Capital Management LLC (0.88%), Temasek Holdings Private Ltd (0.73%) and Dimensional Fund Advisors LP (0.70%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, Andrew J Thomson, C Martin Harris, Daniel P Shine, Edward A Pesicka, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas J Lynch, Thomas W Loewald, Tyler Jacks and William G Parrett.

Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Fred Alger Management Inc., Foresters Investment Management Company Inc., Nicholas Co. Inc. WI, ARS Investment Partners LLC, Aberdeen Asset Management PLC UK, Quest Investment Management Inc. OR and AMF Pensionsforsakring AB. Company insiders that have sold Thermo Fisher Scientific stock in the last year include Alan J Malus, C Martin Harris, Daniel P Shine, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald.

Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was bought by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Russell Investments Group Ltd., Janus Capital Management LLC, Renaissance Technologies LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Levin Capital Strategies L.P., Asset Management One Co. Ltd. and State Street Corp.

How do I buy Thermo Fisher Scientific stock?

Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Thermo Fisher Scientific stock cost?

One share of Thermo Fisher Scientific stock can currently be purchased for approximately $158.02.

Thermo Fisher Scientific (NYSE:TMO) Chart for Thursday, February, 23, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Earnings History Chart

Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Dividend History Chart

Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Last Updated on 2/23/2017 by Staff